KELLIE BAGI: Open Payments
NPI 1093368631 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 98 payments from 16 companies in 2025. Trend: 2023 $3,487 · 2024 $2,786 · 2025 $1,835
Food & beverage: $1,835
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $547 |
| Boston Scientific Corporation | 26 | $291 |
| PFIZER INC. | 8 | $153 |
| Axsome Therapeutics, Inc. | 7 | $146 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Amgen Inc. | 5 | $108 |
| Neurocrine BioSciences, Inc. | 5 | $96 |
| UCB, Inc. | 3 | $68 |
| ACADIA Pharmaceuticals Inc | 3 | $62 |
| Janssen Biotech, Inc. | 3 | $61 |
Products named: QULIPTA, Infinion 16, NURTEC ODT, Symbravo, KESIMPTA, UBRELVY, INGREZZA, UPLIZNA.
Industry payments across AL — which companies pay providers there.
